Integer Holdings Corporation (ITGR)
NYSE: ITGR · Real-Time Price · USD
109.58
+2.25 (2.10%)
At close: Aug 13, 2025, 4:00 PM
109.58
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Integer Holdings Revenue
Integer Holdings had revenue of $476.49M in the quarter ending June 27, 2025, with 11.36% growth. This brings the company's revenue in the last twelve months to $1.79B, up 9.64% year-over-year. In the year 2024, Integer Holdings had annual revenue of $1.72B with 10.35% growth.
Revenue (ttm)
$1.79B
Revenue Growth
+9.64%
P/S Ratio
2.04
Revenue / Employee
$163,164
Employees
11,000
Market Cap
3.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.72B | 160.94M | 10.35% |
Dec 31, 2023 | 1.56B | 224.38M | 16.85% |
Dec 31, 2022 | 1.33B | 110.20M | 9.02% |
Dec 31, 2021 | 1.22B | 147.64M | 13.75% |
Dec 31, 2020 | 1.07B | -184.65M | -14.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 28, 2018 | Pro | Pro | Pro |
Dec 29, 2017 | Pro | Pro | Pro |
Dec 30, 2016 | Pro | Pro | Pro |
Jan 1, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ITGR News
- 1 day ago - Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4 - GlobeNewsWire
- 18 days ago - Integer Holdings Corporation (ITGR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Integer Holdings Corporation Reports Second Quarter 2025 Results - GlobeNewsWire
- 4 weeks ago - Integer Appoints Michael Coyle to Board of Directors - GlobeNewsWire
- 5 weeks ago - The Best Growth Stocks to Buy - Kiplinger
- 6 weeks ago - Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 - GlobeNewsWire
- 6 weeks ago - Integer Announces Conference Call to Discuss Second Quarter 2025 Results - GlobeNewsWire
- 2 months ago - Integer to Present at Truist Securities MedTech Conference on June 17 - GlobeNewsWire